25 related articles for article (PubMed ID: 2417133)
1. Ticlopidine as an experimental antithrombotic agent.
Vallée E; Maffrand JP; Bernat A; Delebassée D; Tissinier A
Agents Actions Suppl; 1984; 15():50-9. PubMed ID: 6592945
[No Abstract] [Full Text] [Related]
2. In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
Dunn FW; Soria J; Soria C; Thomaidis A; Lee H; Caen JP
Agents Actions Suppl; 1984; 15():97-104. PubMed ID: 6091425
[No Abstract] [Full Text] [Related]
3. Ex vivo effects of ticlopidine on human platelets: inhibition of fibrinogen binding by a mechanism independent of thromboxane formation.
Iovine C; d'Avenia V; Turco S; Mattioli PL; di Minno G
Agents Actions Suppl; 1984; 15():105-7. PubMed ID: 6592941
[No Abstract] [Full Text] [Related]
4. Effects of ticlopidine on platelet function and blood coagulation.
Violi F; Alessandri C; Frattaroli S; Ghiselli A; Balsano F
Thromb Haemost; 1982 Oct; 48(2):166-8. PubMed ID: 6217577
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
Ashida S; Sakuma K; Abiko Y
Thromb Res; 1980 Mar; 17(5):663-71. PubMed ID: 7385100
[No Abstract] [Full Text] [Related]
6. [Changes of blood coagulability and effects of the platelet aggregation inhibitor (ticlopidine) in experimental subarachnoid hemorrhage in dogs].
Toyoda O; Nukui H; Horikoshi S; Mitsuka S; Sasaki H; Tamada J; Miyagi O; Shibasaki T; Ohe C
Neurol Med Chir (Tokyo); 1985 Oct; 25(10):810-7. PubMed ID: 2417133
[No Abstract] [Full Text] [Related]
7. Overview: pharmacology of ticlopidine.
Gordon JL
Agents Actions Suppl; 1984; 15():108-15. PubMed ID: 6385643
[No Abstract] [Full Text] [Related]
8. Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.
Picard-Fraire C
Thromb Res Suppl; 1983; 4():119-28. PubMed ID: 6356462
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and metabolic characteristics of ticlopidine in relation to its inhibitory properties on platelet function.
Picard-Fraire C
Agents Actions Suppl; 1984; 15():68-75. PubMed ID: 6385655
[No Abstract] [Full Text] [Related]
10. [Hemorrhagic changes induced by drug].
Jiménez R
Sangre (Barc); 1978; 23(5):554-66. PubMed ID: 368999
[No Abstract] [Full Text] [Related]
11. [Platelet aggregation and antiaggregant drugs].
Andriani A; Chiappetta MG; Fabiani M
Recenti Prog Med; 1982 Nov; 73(5):537-42. PubMed ID: 6761807
[No Abstract] [Full Text] [Related]
12. Inhibition mechanisms of hematophagous invertebrate compounds acting on the host blood coagulation and platelet aggregation pathways.
Urata J; Shojo H; Kaneko Y
Biochimie; 2003 May; 85(5):493-500. PubMed ID: 12763308
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
